Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 3
Ce profil est validé par 3 label.

Company

ExactCure

ExactCure_logo
38
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

We develop a Digital Health solution to properly use drugs. Our Digital Twin simulates the concentration of drugs in the blood of a patient based on his personal characteristics in order to avoid under-doses, overdoses and drug-drug interactions.

Nice, Provence-Alpes-Côte d'Azur, France

Send a message

Anglais

ExactCure

Anglais

ExactCure develops a Digital Health solution to properly use drugs. Our Digital Twin simulates the concentration of drugs in the blood of a patient based on his/her personal characteristics in order to avoid under-doses, overdoses and drug-drug interactions. Our disruptive technology is based on fundamental research.

 

We provide Personalised Drug Simulations as a Service. Thanks to our API, third-party...

See more

ExactCure develops a Digital Health solution to properly use drugs. Our Digital Twin simulates the concentration of drugs in the blood of a patient based on his/her personal characteristics in order to avoid under-doses, overdoses and drug-drug interactions. Our disruptive technology is based on fundamental research.

 

We provide Personalised Drug Simulations as a Service. Thanks to our API, third-party platforms can integrate our simulations into their solution towards healthcare professionals and patients.

 

We developed our own end-user interfaces, that can be white-labelled (download ExaMed: Android or iOS).

 

Our solution is a Medical Device.

 

In 2021 our revenue grew by 50% vs 2020, and during Q1'22 our revenue represented 104% of FY'2021. Our customers include UPSA (download Med&Moi: Android or iOS), Vidal, Elsevier and US-based Tabula Rasa Healthcare.

 

We are a member of an international H2020 project on in silico simulations for clinical trials on cardio-vascular diseases. ExactCure was mentioned in an article by the Harvard Business Review, and the MIT invited us to be a speaker at their "AI for Healthcare" summit.

 

We expand our drug coverage chronic disease by chronic disease.

 

Our MISSION is to provide personalized drug simulations to healthcare professionals and patients.

Our VISION is a world where medication errors are a thing of the past.

Our AMBITION is to become the worldwide reference in personalized medication simulations.

Our latest news

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Adhérent Medicen
52 Entities
INRIA
8 Entities
Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1480 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members
Access2EIC
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
2139 Members
Les Deeptech
Les Deeptech, c’est la communauté qui rassemble les startups deeptech françaises et les investisseurs désirant développer des relations business avec elles.
358 Members